Subcutaneous tissue cages for examination of slow release of materials from long-term implants

Biomaterials ◽  
1990 ◽  
Vol 11 (1) ◽  
pp. 46-49 ◽  
Author(s):  
Paula S. Leppert ◽  
Joseph A. Fix
Keyword(s):  
Slow Release ◽  
Subcutaneous Tissue

Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide

1994 ◽  
Vol 131 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Josef Marek ◽  
Václav Hána ◽  
Michal Kršek ◽  
Vlasta Justová ◽  
France Catus ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Slow Release ◽  
Serum Levels ◽  
Term Treatment ◽  
Somatostatin Analogue ◽  
Tumour Mass ◽  
Long Term Treatment ◽  
Active Acromegaly ◽  
One Year

Marek J, Hána V. Kršek M. Justová V, Catus F, Thomas F. Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. Eur J Endocrinol 1994;131:20–6. ISSN 0804–4643 Thirteen patients with active acromegaly despite previous surgery were treated with 30 mg lanreotide im twice a month for 9 months. In 10 subjects the treatment continued to 19 months. GH serum levels of all patients decreased significantly from an initial value of 32.0 (29.4) μg/l [median (standard error of median)] to 10.0 (3.6) and 19.1 (5.7) after 3 and 9 months of treatment, respectively. In the 10 patients with the treatment longer than one year the decrease in GH was from 46.8 (29.4) μg/l to 12.5 (5.0) and 16.1 (5.3) after 13 and 19 months, respectively. IGF-I serum levels decreased significantly from 1193 (73)μg/l to 782 (99) and 621 (103) after 3 and 9 months, respectively, and were normalized in 3 patients. In the 10 patients treated for longer than one year, levels decreased significantly from 1318 (74)μg/l to 653 (170) and 742 (180) after 13 and 19 months, respectively. IGF BP-3 levels were reduced to the normal range in 6 patients and decreased from 8.7 (1.5)mg/l to 6.4 (0.8) and to 5.4 (1.0) after 3 and 9 months, respectively. In the patients with the 19 months treatment the decrease was from 9.3 (1.6) mg/l to 3.9 (0.9) and 4.8 (0.9) after 13 and 19 months, respectively. The IGF BP-3 to IFG I ratio increased in 7 patients. This elevation significantly correlated with the decrease in bioassayable somatomedin. Prolactin serum levels fell in all patients with increased prolactin secretion. Testosterone plasma levels increased in 4 out of 5 men without replacement therapy. Clinical improvement was observed in all patients. A reduction of tumour mass was observed in five patients and complete disappearance of the tumour in one subject. All patients complained of mild abdominal pain and softened stools for several days following the injections. However, these side effects never required interruption of treatment. Asymptomatic microlithiasis was seen in only one patient after 13 months, which led to treatment being suspended for a period of 3 months after which it was resumed. Fasting serum insulin and insulin area under the curve (AUC) after oral glucose tolerance test (OGTT) fell in all patients. Fasting blood glucose, fructosamine and glucose AUC after OGTT slightly increased during the treatment, but all blood glucose levels (fasting and during OGTT) remained within normal ranges. Lanreotide appears to be a safe and effective treatment in patients with active acromegaly unresolved by surgery. The long-acting formulation avoids the drawbacks associated with either repeated daily injections or continuous infusions of somatostatin analogues. Josef Marek, Third Department of Medicine, Charles University, U nemocnice 1, 128 21 Praha 2, The Czech Republic

scholarly journals Slow-release fertilizers and possibilities of their utilizing in nursery

2004 ◽  
Vol 52 (2) ◽  
pp. 155-164
Author(s):  
Petr Salaš
Keyword(s):  
Slow Release ◽  
Ornamental Plants ◽  
Woody Species ◽  
Soil Surface ◽  
Berberis Thunbergii ◽  
Slow Release Fertilizers ◽  
Picea Omorika ◽  
One Year ◽  
Two Stages

Reserve, slow-release fertilizers (SRF) enable to simplify the whole system of plant nutrition and fertilisation. Tabletted fertilizers of the Silvamix series represent a prospective product of Czech provenience. At our university, these fertilizers have been tested and used since the year 1991. Ornamental woody species grown in containers were investigated in two stages. Experiments with ornamental plants were established using one-year-old cuttings and seedlings of the following deciduous and evergreen woody species:Cotoneaster dammeri Skogholm,Berberis thunbergii,Potentilla fruticosa Snowflake,Ligustrum vulgare AtrovirensandPicea omorika. After planting into containers, fertilizers in the dose of 1 tablet (i.e. 10 g) per litre of substrate were applied either to roots level or on the soil surface in the container. Silvamix in the dose of 5 g.l-1was used as the tested fertilizer in the second stage. It was applied during the planting in the form of tablets and/or a powder. Control plants were fertilized in the course of growing season using a common agricultural fertilizer Cererit Z. The annual plants increments were measured. These experiments demonstrated a long-term optimum effect of this product on woody species and an equal quality and efficiency of its tabletted and powdered forms.

The Use of Slow-Release Artificial Tears in the Long-Term Management of Keratitis Sicca

Ophthalmology ◽  
1981 ◽  
Vol 88 (1) ◽  
pp. 78-81 ◽  
Author(s):  
Theodore P. Werblin ◽  
Stephen D. Rheinstrom ◽  
Herbert E. Kaufman
Keyword(s):  
Slow Release ◽  
Artificial Tears ◽  
Keratitis Sicca ◽  
Term Management

scholarly journals Novel Slow Release Nanocomposite Fertilizers

2020 ◽  
Author(s):  
Muthuraman Yuvaraj ◽  
Kizhaeral Sevathapandian Subramanian
Keyword(s):  
Soil Microorganisms ◽  
Slow Release ◽  
Economic Advantage ◽  
Nutrient Loss ◽  
Environment And Health ◽  
Atom Manipulation ◽  
Agricultural Sciences ◽  
Energy Environment ◽  
The Subject

Nanotechnology deals with atom-by-atom manipulation and the strategies and products developed are quite precise. Despite the fact that the nanotechnology is noticeably exploited in the subject of energy, environment and health, the research is agricultural sciences had just scratched the surface. However, the potentials of nanotechnology in agricultural sciences had been reviewed. Among the applications, nanofertilizers technology is very revolutionary and known to exhibit economic advantage if the products advanced are economically feasible and socially sustainable. These nano fertilizers are pronounced to reduce nutrient loss due to leaching, emissions, and long-term incorporation by soil microorganisms.

scholarly journals Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal

Life Sciences ◽  
2017 ◽  
Vol 185 ◽  
pp. 1-7 ◽  
Author(s):  
Virginia D. McLane ◽  
Ivy Bergquist ◽  
James Cormier ◽  
Deborah J. Barlow ◽  
Karen L. Houseknecht ◽  
...  
Keyword(s):  
Plasma Concentration ◽  
Slow Release ◽  
Precipitated Withdrawal ◽  
Osmotic Pumps

Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01).

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 9001-9001 ◽  
Author(s):  
Michael A. Henderson ◽  
Bryan Burmeister ◽  
Jill Ainslie ◽  
Richard Fisher ◽  
Julianna Di Iulio ◽  
...  
Keyword(s):  
High Risk ◽  
Randomized Trial ◽  
Adjuvant Radiotherapy ◽  
Subcutaneous Tissue ◽  
Final Report ◽  
Metastatic Node ◽  
Logrank Test ◽  
Long Term Treatment ◽  
Melanoma Patients

9001 Background: The role of adjuvant radiotherapy following lymphadenectomy in melanoma patients identified as at high risk for further recurrence has been controversial. This final report of a multicenter randomized trial updates survival and lymph node field (LNF) control, and reports long term treatment toxicity, lymphedema and quality of life (QOL) (Lancet Oncol 2012;13:589-97). Methods: Patients at high risk of LNF relapse (≥1 parotid, ≥2 cervical or axillary or ≥3 groin positive nodes; or extra-nodal spread of tumour; or minimum metastatic node diameter of 3cm (neck or axilla) or 4cm (groin)) received adjuvant radiotherapy (ART) (48Gy in 20 fractions) or observation (OBS). LNF relapse, as a 1st relapse, was the primary endpoint; morbidity, QOL, patterns of relapse, disease free and overall survival were secondary endpoints. A target sample size of 250 enabled detection of a difference in 3 year relapse rates of 30% and 15% to be detected (2-sided logrank test, power of 80%). Results: 250 patients from 16 centres were randomized from Mar 02 to Sept 07 (123 ART; 127 OBS) with 217 fully eligible (109 ART, 108 OBS). Mean follow-up 73 months (range 21–116). LNF recurrence was reduced in the ART arm (HR=0.52 (0.31- 0.88) p=0.023) but there was no difference in survival (HR=1.13 (0.82 – 1.55) p =0.21). QOL was assessed by comparison of area under the curve from baseline to 5 years (or recurrence) with the FACT-G tool using both total score and the 4 major domains (physical, social, emotional and functional wellbeing), no difference. Regional symptoms (standardised questionnaire) were higher in the ART arm (p=0.035). Limb volumes were higher in the ART arm (leg 7.3% difference p=0.014, arm 3.4% p=0.25). Grade 2-4 RT toxicity was common for head + neck: skin (33%); axilla: skin (44%), subcutaneous tissue (41%); Groin: skin (46%), subcutaneous tissue (67%), other (38%). Conclusions: RT reduced the risk of LNF relapse by 52% but there was no impact on survival. In the ART arm loco-regional symptoms were worse, limb volumes were somewhat increased and Grade 2 - 4 long term RT toxicity was relatively common. However QOL as assessed by a validated tool (FACT-G) was similar in both groups. Clinical trial information: NCT00287196.

Sign in / Sign up

Export Citation Format

Share Document